No abstract available
MeSH terms
-
Anti-Infective Agents / therapeutic use*
-
Blood Glucose / metabolism
-
Humans
-
Protein C / therapeutic use
-
Pyelonephritis / complications
-
Pyelonephritis / therapy
-
Recombinant Proteins / therapeutic use
-
Renal Insufficiency / etiology
-
Renal Insufficiency / prevention & control
-
Respiratory Insufficiency / etiology
-
Respiratory Insufficiency / prevention & control
-
Risk Factors
-
Sepsis / therapy
-
Urinary Catheterization / adverse effects
-
Urinary Tract Infections / complications
-
Urinary Tract Infections / diagnosis
-
Urinary Tract Infections / drug therapy
-
Urinary Tract Infections / etiology
-
Urinary Tract Infections / prevention & control
-
Urinary Tract Infections / therapy*
-
Venous Thrombosis / etiology
-
Venous Thrombosis / prevention & control
Substances
-
Anti-Infective Agents
-
Blood Glucose
-
Protein C
-
Recombinant Proteins
-
drotrecogin alfa activated